The metabolic cost of lowering blood pressure with hydrochlorothiazide

BACKGROUND: The landmark Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT) placed a new spotlight on thiazide diuretics as the first-line therapy for hypertension. This is concerning as thiazide-diuretics may contribute to comorbidities associated with the current...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Price, Angela L, Lingvay, Ildiko, Szczepaniak, Edward W, Wiebel, Jaime, Victor, Ronald G, Szczepaniak, Lidia S
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2013
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3711837/
https://ncbi.nlm.nih.gov/pubmed/23837919
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1758-5996-5-35
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller